Viewing StudyNCT04758962



Ignite Creation Date: 2024-05-06 @ 3:46 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04758962
Status: COMPLETED
Last Update Posted: 2024-01-18
First Post: 2021-02-08

Brief Title: A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-02-15
Start Date Type: ACTUAL
Primary Completion Date: 2021-06-04
Primary Completion Date Type: ACTUAL
Completion Date: 2022-04-19
Completion Date Type: ACTUAL
First Submit Date: 2021-02-08
First Submit QC Date: February 16 2021
Study First Post Date: 2021-02-17
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-01-17
Last Update Post Date: 2024-01-18
Last Update Post Date Type: ACTUAL